US Patent Issued to Ossianix on July 8 for "TFR-specific binding moieties and transcytosis method to select VNARs that cross cellular barriers" (British, American Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,642, issued on July 8, was assigned to Ossianix Inc. (Bryn Mawr, Pa.).

"TFR-specific binding moieties and transcytosis method to select VNARs that cross cellular barriers" was invented by Krzysztof B. Wicher (Cambridge, Great Britain), Julia Lynn Rutkowski (Bryn Mawr, Pa.) and Pawel Stocki (Royston, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the fields of molecular medicine and targeted delivery of therapeutic or diagnostic agents to cells outside the vascular system and into the parenchymal tissue of organs within the body. More specifically, the present invention relates to improved TfR-binding moi...